Journal of Family Medicine and Primary Care 2019 8(1):289-297
We present the case of a 28-year-old female who presented for primary care at 22-week gestation with type II achalasia and worsening solid/liquid dysphagia leading to pregnancy weight loss. Considering that durable therapies such as surgical myotomy and pneumatic dilatation have considerable risk, botulinum A toxin injection was selected as a temporizing bridging therapy. She had an uncomplicated post procedure course and had significant rapid improvement in dysphagia symptoms, which enabled her to progress to normal peripartum weight. This case highlights the need for early recognition of achalasia and an unique niche for use of botulinum toxin A as a temporizing therapy in this risk averse population.
from ! Human Diseases via Alexandros G.Sfakianakis on Inoreader http://bit.ly/2CZSI96
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου